1. Lipopeptide iturin C 3 from endophytic Bacillus sp. effectively inhibits biofilm formation and prevents the adhesion of topical and food-borne pathogens in vitro and on biomedical devices.
- Author
-
Adhikary R, Maiti PK, Ghosh N, Rajbanshi B, Roy MN, Mandal S, and Mandal V
- Subjects
- Humans, Microbial Sensitivity Tests, Peptides, Cyclic pharmacology, Peptides, Cyclic chemistry, Lipopeptides pharmacology, Lipopeptides chemistry, Surface-Active Agents pharmacology, Surface-Active Agents chemistry, Endophytes chemistry, Endophytes physiology, Endophytes metabolism, Cell Line, Bacteria drug effects, Biofilms drug effects, Bacillus chemistry, Bacillus physiology, Bacillus drug effects, Bacterial Adhesion drug effects, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents chemistry
- Abstract
Iturin, a structurally cyclic heptapeptides with a number of homologous derivatives has broad-spectrum antimicrobial and antibiofilm properties. The present study elucidates the structure and antimicrobial efficacy of iturin C
3 biosurfactant (BS) produced by the endophytic bacterium Bacillus sp. LLB-04. Bacillus sp. LLB-04 was isolated from the leaves of hemiparasite Scurrula parasitica L. during the winter season. The biosurfactant was produced in a static batch culture of 120 h using Nutrient Broth (NB) medium and was extracted by a series of solvent systems. The BS was purified by solvent fractionation and preparative High-Performance Liquid Chromatography (HPLC) method, and then it was structurally characterized through various analytical methods. Its antimicrobial and antibiofilm activities were tested against 0, to 18 h old topical and food-borne pathogens. Furthermore, the cellular aggregation and bacterial cell adhesion on polystyrene and urethral catheters were checked at the Biofilm inhibitory concentration (BIC). The cell line toxicity of BS (0-1.568 mg/ml) was tested against the human embryonic lung tissue L-132 and human alveolar epithelial cancer cell line, and the in silico mode of action was studied using standard methods. From the spectroscopic studies of 96 h culture harvested BS revealed that Bacillus sp. LLB-04 (GenBank Accession No.: MF037706) produced the BS as iturin C3 . The BS had broad-spectrum antimicrobial with minimum inhibitory concentration (MIC) values ranging from 0.1 to 1.6 mg/ml and an average biofilm inhibition concentration (BIC) of 0.8-1.6 mg/ml in 18 h old cells where biofilm formation was inhibited up to 46.4 times at 1.6 mg/ml concentration. It could also destabilize 40-48 h old preformed biofilm and had a synergistic response with streptomycin (Bacillus subtilis MTCC 411, Escherichia coli MTCC 730), ciprofloxacin (B. subtilis MTCC 411, E. coli MTCC 730), and vancomycin (Staphylococcus epidermidis MTCC 3086, B. subtilis MTCC 411). It had antiproliferative activity (0.1-0.8 mg/ml) on cancer cell lines. In-silico protein-ligand interactions predicted that it could interact with different membrane proteins of topical and food-borne pathogens. Thus, the study revealed for the first time that the endophytic Bacillus sp. could be exploited for large-scale production of iturin C3 that could be used in combating biofilm formation and cellular adhesion of topical and food-borne pathogens., Competing Interests: Declarations. Conflict of interest: The authors declare that they have no conflict of interest. NCBI database ID: MF037706., (© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)- Published
- 2025
- Full Text
- View/download PDF